ProMIS Neurosciences is trading 7% up today at $15.05 as the stock rebounds from recent volatility and follows a broad risk-on rally in U.S. equities.
- The move is occurring without fresh company-specific news, appearing to track the recovery of high-beta, small-cap biotech names.
- Major indices are up more than 1% today, providing a tailwind for the sector alongside improving sentiment in the technology market.